Categories
Latest News

SA Pathology in Adelaide, S.A. has approved the flocked nasopharyngeal swabs produced by 3D Printing Studios  

The global pandemic of COVID-19 disease has been caused by the coronavirus known as SARS-CoV-2.

The recommended diagnostic investigation for acute SARS-CoV-2 infection is a nucleic acid amplification test (NAT) on a combined throat and nasopharyngeal swab.

There has been a global shortage of swabs suitable for the collection of samples to test for SARS-CoV-2.

In the absence of a local producer, Australia has been sourcing all diagnostic swabs from international manufacturers. Australian laboratories have had problems securing swab supplies as other countries struggle with their own COVID-19 crises and the increased demand for swabs.

In an attempt to provide Australian-produced swabs thereby securing this critical supply chain, 3D printed swabs have been investigated by at least two local manufacturers in partnership with Australian laboratories.

SA Pathology partnered with 3D Printing Studios to evaluate the 3D swabs produced by the company.

All swabs are produced on-site, using PA2200 nylon material which is TGA & FDA approved for medical external use, then flocking the swab using Decitex flock.

This evaluation used a variety of investigations to compare swabs produced by 3D Printing Studios with currently-available commercial swabs sourced overseas

This evaluation agreed with the findings of two recently-published studies comparing 3D printed and standard commercial swabs. All three studies have reported that the 3D printed swabs have performance characteristics similar to standard commercial swabs

In conclusion, the swabs were macroscopically similar to commercial swabs; demonstrated superior water absorbance, and captured a statistically-similar amount of human DNA material as a commercial swab.

This makes 3D Printing Studios the first Australian company to manufacture medical nasopharyngeal swabs, essential products in the fight against COVID-19.

This will reduce the need to import these vital products while bringing
manufacturing back to Australia.

3D Printed Swabs ready for sale

For more information, please Contact us

Categories
Business Case Latest News

Locally 3D mass-manufactured COVID swabs end Australian reliance on overseas supply

Australian Company 3D Printing Studios has been working with State, Government, and Health Departments to produce Medical Nasal & Throat Swabs used in Covid-19 Test Kits.  

South Australian Pathology has tested the latest 3D printed swabs and has given the green light on its use. This will make 3D Printing Studios the only Australian Supplier of these essential products in the fight against Covid-19.

The process of developing a swab that not only collects the mucus but also allows for the mucus to be transferred for testing has taken several weeks to develop.

“We tried several different 3d printed designs obtained from Harvard Medical School and finally came up with a simple design that is flocked with a safe nylon material,” said Howard Wood.

“The design coupled with the EOS P396 machinery will allow us to produce thousands of these medical swabs per day”. 

Some of the many designs that were tested

Howard Wood & Stuart Grover owners of 3D Printing Studios are delighted to be the first Australian Company to manufacture medical nasal swabs, this will reduce our need to import these vital products and once again start bringing manufacturing back to Australia.

The final Medical Nasal & Throat Swabs ready to be used in the Covid-19 Test Kits

For more information on manufacturing products locally  

Contact us